MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Maha-Karnataka language row: Family to withdraw POCSO case against conductor

RTC bus staff attack: Kannada organisations call for Karnataka bandh on March 22